Micron Technology
MU
NVIDIA
NVDA
Intel
INTC
Adobe
ADBE
Salesforce
CRM
US Stock MarketDetailed Quotes
KKPCF KAKEN PHARMACEUTICAL
- 29.199
- 0.0000.00%
15min DelayClose Dec 9 16:00 ET
1.11BMarket Cap9.54P/E (TTM)
0.000High0.000Low0Volume0.000Open29.199Pre Close0.00Turnover0.00%Turnover Ratio21.61P/E (Static)37.87MShares29.19952wk High1.10P/B1.11BFloat Cap21.50652wk Low1.04Dividend TTM37.87MShs Float29.199Historical High3.58%Div YieldTTM0.00%Amplitude21.506Historical Low--Avg Price1Lot Size
KAKEN PHARMACEUTICAL Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.57%18.25B | -1.29%72.04B | -0.30%17.36B | -1.28%18.51B | -3.23%18.02B | -0.26%18.15B | -4.01%72.98B | -4.99%17.41B | -6.79%18.75B | -2.68%18.62B |
| Operating revenue | 0.57%18.25B | -1.29%72.04B | -0.30%17.36B | -1.28%18.51B | -3.23%18.02B | -0.26%18.15B | -4.01%72.98B | -4.99%17.41B | -6.79%18.75B | -2.68%18.62B |
| Cost of revenue | 1.33%8.2B | 0.23%33.51B | 3.11%8.68B | -2.37%8.38B | 0.98%8.36B | -0.77%8.09B | -2.99%33.43B | -4.00%8.42B | -5.75%8.58B | -1.62%8.28B |
| Gross profit | -0.04%10.05B | -2.57%38.54B | -3.49%8.68B | -0.34%10.14B | -6.60%9.66B | 0.16%10.06B | -4.86%39.56B | -5.89%8.99B | -7.67%10.18B | -3.52%10.35B |
| Operating expense | 7.97%7.3B | -8.02%29.02B | -39.96%8.04B | 13.17%6.78B | 20.18%7.44B | 13.02%6.76B | 28.75%31.55B | 109.83%13.39B | -2.89%5.99B | 1.41%6.19B |
| Research and development costs | 15.31%3B | -20.56%12.54B | -57.37%4.04B | 39.60%2.76B | 36.43%3.14B | 28.08%2.6B | 87.52%15.79B | 297.44%9.48B | -2.32%1.98B | 7.33%2.3B |
| -Depreciation and amortization | ---- | 8.93%317M | ---- | ---- | ---- | ---- | 12.79%291M | ---- | ---- | ---- |
| Other operating expenses | 8.15%2.57B | 9.18%9.04B | 1.61%1.83B | 1.30%2.25B | 22.65%2.58B | 10.50%2.38B | -1.71%8.28B | -3.48%1.8B | -3.72%2.23B | -1.82%2.1B |
| Operating profit | -16.48%2.75B | 18.93%9.52B | 114.59%641M | -19.69%3.36B | -46.54%2.22B | -18.80%3.3B | -53.11%8B | -238.35%-4.39B | -13.75%4.19B | -10.03%4.15B |
| Net non-operating interest income expense | 50.00%-1M | 10.00%-9M | 33.33%-2M | -50.00%-3M | 0.00%-2M | 33.33%-2M | 9.09%-10M | 25.00%-3M | 0.00%-2M | 0.00%-2M |
| Non-operating interest income | 100.00%4M | 14.29%8M | 0.00%2M | 0.00%2M | 0.00%2M | 100.00%2M | 16.67%7M | 100.00%2M | 0.00%2M | 0.00%2M |
| Non-operating interest expense | 25.00%5M | 0.00%17M | -20.00%4M | 25.00%5M | 0.00%4M | 0.00%4M | 0.00%17M | 0.00%5M | 0.00%4M | 0.00%4M |
| Other net income (expense) | ||||||||||
| Special income (charges) | 10.81%-33M | 91.26%-167M | 94.98%-79M | -111.11%-19M | -700.00%-32M | 88.54%-37M | 47.79%-1.91B | 58.50%-1.57B | 18.18%-9M | -102.67%-4M |
| -Less:Other special charges | -10.81%33M | 214.89%148M | 300.00%60M | 111.11%19M | 700.00%32M | 94.74%37M | -92.92%47M | -98.12%15M | -18.18%9M | 102.67%4M |
| -Write off | ---- | -98.98%19M | -98.78%19M | ---- | ---- | --0 | -37.78%1.86B | -47.93%1.56B | --0 | --0 |
| Other non- operating income (expenses) | -300.00%-4M | -82.93%57M | -85.47%25M | -65.91%15M | -78.26%15M | -95.92%2M | 158.91%334M | 207.14%172M | 100.00%44M | 263.16%69M |
| Income before tax | -31.30%2.37B | 43.70%9.8B | 109.89%576M | -19.27%3.56B | -47.71%2.21B | -13.90%3.45B | -50.90%6.82B | -918.18%-5.82B | -12.13%4.41B | -11.71%4.22B |
| Income tax | -34.36%617M | 28.54%1.77B | 63.36%-775M | -22.17%955M | -44.21%650M | -14.55%940M | -68.24%1.38B | -1,792.00%-2.12B | -18.04%1.23B | -18.07%1.17B |
| Net income | -30.12%1.75B | 47.52%8.03B | 136.40%1.35B | -18.15%2.61B | -49.04%1.56B | -13.66%2.51B | -43.03%5.44B | -432.14%-3.71B | -9.65%3.19B | -8.99%3.06B |
| Net income continuous Operations | -30.15%1.75B | 47.54%8.03B | 136.42%1.35B | -18.15%2.61B | -49.05%1.56B | -13.65%2.51B | -43.03%5.44B | -432.14%-3.71B | -9.62%3.19B | -9.02%3.06B |
| Minority interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Net income attributable to the parent company | -30.12%1.75B | 47.52%8.03B | 136.40%1.35B | -18.15%2.61B | -49.04%1.56B | -13.66%2.51B | -43.03%5.44B | -432.14%-3.71B | -9.65%3.19B | -8.99%3.06B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -30.12%1.75B | 47.52%8.03B | 136.40%1.35B | -18.15%2.61B | -49.04%1.56B | -13.66%2.51B | -43.03%5.44B | -432.14%-3.71B | -9.65%3.19B | -8.99%3.06B |
| Basic earnings per share | -30.86%46.32 | 46.87%212.67 | 136.11%35.57 | -18.89%68.92 | -49.42%41.19 | -12.90%66.99 | -42.41%144.8 | -447.89%-98.51 | -8.80%84.97 | -7.95%81.43 |
| Diluted earnings per share | -30.86%46.32 | 46.87%212.67 | 135.94%35.57 | -18.98%68.841 | -49.42%41.19 | -12.90%66.99 | -42.41%144.8 | -437.04%-98.9781 | -8.80%84.97 | -7.95%81.43 |
| Dividend per share | 0 | 0.00%150 | 0.00%75 | 0 | 0.00%75 | 0 | 0.00%150 | 0.00%75 | 0 | 0.00%75 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.